EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibitory Mechanism of Bee Venom Against A431 Cutaneous Squamous Cell Carcinoma Cells Based on Label-Free Proteomics and Untargeted Metabolomics

Ao Yang, Jingjing Li, Wenchao Yang iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27198725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ao Yang und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Bee Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China. Hauptthemen laut MEDLINE: Bee Venoms, Proteomics, Metabolomics, Skin Neoplasms. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Agriculture and Forestry University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of cutaneous squamous cell carcinoma (cSCC) has been rising steadily in recent years, yet treatment options for advanced-stage patients remain limited. Bee venom (BV) possesses diverse biological activities including inhibiting tumor cell growth in various tumor models, but its underlying mechanism against cSCC A431 cells remains unclear. This study evaluated the antiproliferative effect of BV on A431 cells using the CCK-8 assay and explored its mechanism of action through label-free proteomics and untargeted metabolomics. BV inhibited A431 cell proliferation in a dose-dependent manner, with a half-maximal inhibitory concentration of 11.57 μg/mL. Proteomics analysis revealed that 118 differentially expressed proteins were mainly enriched in the p53 signaling pathway, mineral absorption, and base excision repair pathways. Metabolomics screening yielded 336 differentially expressed metabolites, primarily enriched in amino acid biosynthesis and metabolism. BV exerts its anti-A431 cell bioactivity potentially by synergistically regulating tumor-related signaling pathways, mineral homeostasis, and proteins involved in DNA repair processes, thereby disrupting amino acid biosynthesis and metabolism. But the transcriptomic data failed to confirm TP53 upregulation. These findings provide a theoretical basis for apipuncture and BV-based cSCC therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bee VenomsProteomicsMetabolomicsSkin NeoplasmsCarcinoma, Squamous CellHumansCutaneous Squamous Cell CarcinomaCell Line, TumorCell ProliferationSignal TransductionTumor Suppressor Protein p53Gene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

A431 cellsBee venom (BV)label-free proteomicsuntargeted metabolomics

Substanzen

Bee VenomsTumor Suppressor Protein p53

Autor:innen und Institutionen

  • College of Bee Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China.

ORCID-Profile: Wenchao Yang

Förderung

  • Fujian Agriculture and Forestry University

Zitieren

APA

Yang, A., Li, J., & Yang, W. (2026). Inhibitory Mechanism of Bee Venom Against A431 Cutaneous Squamous Cell Carcinoma Cells Based on Label-Free Proteomics and Untargeted Metabolomics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27198725

Vancouver

Yang A, Li J, Yang W. Inhibitory Mechanism of Bee Venom Against A431 Cutaneous Squamous Cell Carcinoma Cells Based on Label-Free Proteomics and Untargeted Metabolomics. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27198725

BibTeX
@article{Yang2026,
  author = {Yang, Ao and Li, Jingjing and Yang, Wenchao},
  title = {Inhibitory Mechanism of Bee Venom Against A431 Cutaneous Squamous Cell Carcinoma Cells Based on Label-Free Proteomics and Untargeted Metabolomics},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27198725}
}
Kostenlos starten →